Cargando…
Clinical Utility of Genomic Assay in Node-Positive Early-Stage Breast Cancer
Breast cancer (BC) is the most common malignancy among women in Canada. Adjuvant treatment in early BC can reduce the risk of BC recurrence. Historically, the decision for adjuvant chemotherapy for early BC was made only based on clinical and tumour characteristics. In recent years, there has been a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325032/ https://www.ncbi.nlm.nih.gov/pubmed/35877267 http://dx.doi.org/10.3390/curroncol29070407 |